Larry L Wood Edwards Lifesciences Corp (EW) insider trading activity

Larry L Wood is Global President TAVR & Surg of Edwards Lifesciences Corp. Currently has a direct ownership of 198,525 shares of EW, which is worth approximately $14 Million. The most recent transaction as insider was on Nov 05, 2024, when has been sold 25,000 shares (Common Stock) at a price of $65.91 per share, resulting in proceeds of $1,647,750. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 199K

11.18% 3M change

7.14% 12M change

Total Value Held $14 Million

Larry L Wood Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Nov 05 2024	SELL Open market or private sale	$1,647,750 $65.91 p/Share	25,000 Reduced 11.18%	198,525 Common Stock
May 11 2024	SELL Payment of exercise price or tax liability	$85,419 $86.72 p/Share	985 Reduced 0.44%	223,525 Common Stock
May 07 2024	SELL Payment of exercise price or tax liability	$59,137 $85.09 p/Share	695 Reduced 0.31%	224,510 Common Stock
May 07 2024	BUY Grant, award, or other acquisition	-	8,725 Added 3.73%	225,205 Common Stock
May 04 2024	SELL Payment of exercise price or tax liability	$301,870 $85.25 p/Share	3,541 Reduced 1.61%	216,480 Common Stock
May 04 2024	BUY Exercise of conversion of derivative security	-	6,675 Added 2.94%	220,021 Common Stock
May 03 2024	SELL Payment of exercise price or tax liability	$33,598 $85.06 p/Share	395 Reduced 0.18%	213,346 Common Stock
Feb 16 2024	SELL Payment of exercise price or tax liability	$27,274 $86.04 p/Share	317 Reduced 0.15%	213,476 Common Stock
Dec 13 2023	SELL Open market or private sale	$622,163 $71.86 p/Share	8,658 Reduced 3.89%	213,793 Common Stock
Dec 13 2023	BUY Exercise of conversion of derivative security	$392,034 $45.28 p/Share	8,658 Added 3.75%	222,451 Common Stock
Nov 13 2023	SELL Open market or private sale	$567,316 $65.51 p/Share	8,660 Reduced 3.89%	213,793 Common Stock
Nov 13 2023	BUY Exercise of conversion of derivative security	$392,124 $45.28 p/Share	8,660 Added 3.75%	222,453 Common Stock
Oct 13 2023	SELL Open market or private sale	$605,680 $69.94 p/Share	8,660 Reduced 3.89%	213,793 Common Stock
Oct 13 2023	BUY Exercise of conversion of derivative security	$392,124 $45.28 p/Share	8,660 Added 3.75%	222,453 Common Stock
Sep 14 2023	SELL Open market or private sale	$637,635 $73.63 p/Share	8,660 Reduced 3.89%	213,793 Common Stock
Sep 14 2023	BUY Exercise of conversion of derivative security	$392,124 $45.28 p/Share	8,660 Added 3.75%	222,453 Common Stock
Aug 14 2023	SELL Open market or private sale	$509,185 $79.3 p/Share	6,421 Reduced 2.92%	213,793 Common Stock
Aug 14 2023	BUY Exercise of conversion of derivative security	$290,742 $45.28 p/Share	6,421 Added 2.83%	220,214 Common Stock
Jul 14 2023	SELL Open market or private sale	$804,860 $92.94 p/Share	8,660 Reduced 3.89%	213,793 Common Stock
Jul 14 2023	BUY Exercise of conversion of derivative security	$392,124 $45.28 p/Share	8,660 Added 3.75%	222,453 Common Stock
Jun 14 2023	SELL Open market or private sale	$781,911 $90.29 p/Share	8,660 Reduced 3.89%	213,793 Common Stock
Jun 14 2023	BUY Exercise of conversion of derivative security	$392,124 $45.28 p/Share	8,660 Added 3.75%	222,453 Common Stock
May 24 2023	SELL Open market or private sale	$540,840 $84.23 p/Share	6,421 Reduced 2.92%	213,793 Common Stock
May 24 2023	BUY Exercise of conversion of derivative security	$290,742 $45.28 p/Share	6,421 Added 2.83%	220,214 Common Stock
May 11 2023	BUY Grant, award, or other acquisition	-	7,775 Added 3.51%	213,793 Common Stock

Also insider at

PRCT

PROCEPT BioRobotics Corp Healthcare

Director

LLW

Larry L Wood

Global President TAVR & Surg

Irvine, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells EW shares.

Notify only if

Value

Insider Trading

Get notified when an Edwards Lifesciences Corp insider buys or sells EW shares.

Notify only if

Operation

Value

Type

News

Receive news related to Edwards Lifesciences Corp

Track Activities on EW

Account